Susquehanna International Group, LLP Harmony Biosciences Holdings, Inc. Call Options Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
Call Options
12 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$212 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$187 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$151 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$50.6 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$41.3 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.9B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...